As of 2026-10-15, the Relative Valuation of Bionano Genomics Inc (BNGO) is (93.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.37 USD, the upside of Bionano Genomics Inc based on Relative Valuation is -6910.5%.
The range of the Relative Valuation is (98.65) - (91.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.2x - 39.0x | 35.9x |
| Forward P/E multiples | 28.0x - 32.5x | 30.6x |
| Fair Price | (98.65) - (91.13) | (93.30) |
| Upside | -7300.4% - -6751.8% | -6910.5% |
| Date | P/E |
| 2026-10-13 | -0.49 |
| 2026-10-12 | -0.48 |
| 2026-10-09 | -0.51 |
| 2026-10-08 | -0.52 |
| 2026-10-07 | -0.52 |
| 2026-10-06 | -0.52 |
| 2026-10-05 | -0.52 |
| 2026-10-02 | -0.53 |
| 2026-10-01 | -0.56 |
| 2026-09-30 | -0.56 |
| 2026-09-29 | -0.62 |
| 2026-09-28 | -0.60 |
| 2026-09-25 | -0.59 |
| 2026-09-24 | -0.60 |
| 2026-09-23 | -0.61 |
| 2026-09-22 | -0.65 |
| 2026-09-21 | -0.65 |
| 2026-09-18 | -0.62 |
| 2026-09-17 | -0.62 |
| 2026-09-16 | -0.54 |
| 2026-09-15 | -0.56 |
| 2026-09-14 | -0.47 |
| 2026-09-11 | -0.44 |
| 2026-09-10 | -0.43 |
| 2026-09-09 | -0.42 |
| 2026-09-08 | -0.43 |
| 2026-09-04 | -0.43 |
| 2026-09-03 | -0.44 |
| 2026-09-02 | -0.45 |
| 2026-09-01 | -0.44 |
| 2026-08-31 | -0.44 |
| 2026-08-28 | -0.42 |
| 2026-08-27 | -0.43 |
| 2026-08-26 | -0.43 |
| 2026-08-25 | -0.45 |
| 2026-08-24 | -0.44 |
| 2026-08-21 | -0.43 |
| 2026-08-20 | -0.43 |
| 2026-08-19 | -0.44 |
| 2026-08-18 | -0.42 |
| 2026-08-17 | -0.42 |
| 2026-08-14 | -0.42 |
| 2026-08-13 | -0.42 |
| 2026-08-12 | -0.43 |
| 2026-08-11 | -0.42 |
| 2026-08-10 | -0.41 |
| 2026-08-07 | -0.41 |
| 2026-08-06 | -0.39 |
| 2026-08-05 | -0.38 |
| 2026-08-04 | -0.40 |